How long is a typical MOTS-c cycle?
Preclinical MOTS-c research protocols typically run 4-8 weeks of 2-3 times weekly subcutaneous administration. Exercise-physiology research protocols often align with the underlying exercise-intervention duration; metabolic-disease research uses the longer end of the range to capture integrated tissue-level responses.
What the research literature says
The MOTS-c protocol-length framework is informed by the published research literature on metabolic-homeostasis and exercise-synergy contexts. The Lee characterisation work (PMID 25738459) used multi-week protocols to characterise the integrated metabolic-homeostasis phenotype; the follow-up muscle and fat metabolism work (PMID 27216708) used similar multi-week frameworks.
The Yang exercise-synergy work documented synergistic interaction between MOTS-c and exercise intervention in regulating PGC-1α expression and insulin resistance across multi-week protocols (PMID 33722744). The protocol length aligns with the underlying exercise-intervention duration rather than with MOTS-c’s plasma pharmacokinetics. The Kim nuclear-translocation work characterised metabolic-stress-responsive nuclear translocation behaviour across multi-week stress-state durations (PMID 29983246).
The Jiang neuropathic-pain work (PMID 37285113) extended the protocol-length framework into pain-research contexts using similar multi-week durations. The 4-8 week range covers the typical research-supply protocol period across these contexts.
Why this matters in research context
The 4-8 week protocol length is the operational anchor for most MOTS-c research protocols. The cadence (2-3 times weekly) within the protocol is set by the functional response time scale; the overall protocol length is set by the integrated tissue-level response time course. Exercise-physiology research protocols often pair MOTS-c administration with a corresponding exercise-intervention duration of similar length to characterise the synergistic interaction documented in the Yang work.
Related compounds
- MOTS-c 10mg — the compound covered by this answer
Related research questions
References
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab 2015;21(3):443-454. [PMID 25738459]
- Lee C et al. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med 2016;100:182-187. [PMID 27216708]
- Kim KH et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab 2018;28(3):516-524. [PMID 29983246]
- Yang B et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim Biophys Acta Mol Basis Dis 2021;1867(6):166126. [PMID 33722744]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. MOTS-c is sold strictly as a research-grade reagent for laboratory and bench research applications.